Treatment typically involves lifestyle changes, but there are also drug treatments like Wegovy (semaglutide), an injectable GLP-1 medication that is FDA-approved for chronic weight management due to its effectiveness in lowering blood sugar and decreasing appetite
Week 1: Drug levels declining but still pharmacologically active
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
In conscious dogs with pacing-induced dilated cardiomyopathy, 48-hour infusion of recombinant GLP-1 improved LV performance, mediated by increased myocardial glucose uptake via p38 MAP kinasemediated, nitric oxidedependent mechanisms (40, 41)
Your medical history, the reason for your cholecystectomy, any ongoing digestive symptoms, and your overall health status all influence whether these medications represent an appropriate treatment option